“Lost to Follow-up” Among Adult Cancer Survivors

Gill, Amitoj; Gosain, Rohit; Bhandari, Shruti; Gosain, Rahul; Gill, Gurkirat; Abraham, Joseph H.; Miller, Kenneth D.

doi:10.1097/coc.0000000000000408

Cited by 25 publications

(25 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prognostic factors of PMRT with odds ratio (OR) and 95% confidence intervals (95% CIs) for BCSS were analyzed by univariate and multivariate Cox regression hazard model. Considering that an increase in follow-up time would lead to a decrease in the number of patients being followed-up [12], the number of patients with > 5-year BCSS in some subgroups enrolled in this study were small (N < 20), and some of the selected patients tended to have a short follow-up period which may have led to a bias. Hence, we only used the 3-year BCSS to analyze the prognostic survival value.…”

Section: Discussionmentioning

confidence: 99%

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

et al. 2020

View full text Add to dashboard Cite

Background The value of postmastectomy radiotherapy (PMRT) for pathological node-positive triple-negative breast cancers (TNBC) remains debatable. The aim of this population-based retrospective study was to evaluate the effect of PMRT on survival outcomes in this population. Methods Patients diagnosed with stage T1-4N1-N3M0 TNBC between 2010 and 2014 were identified from the Surveillance, Epidemiology, and End Results (SEER) database. We used univariate and multivariate Cox regression hazards method to determine the independent prognostic factors associated with 3-year breast cancer-specific survival (BCSS). The effect of PMRT on 3-year BCSS was analyzed after stratification by pathological staging of groups. Results Of the 4398 patients included in this study, 2649 (60.2%) received PMRT. Younger age, black ethnicity, and advanced tumor (T) and nodal (N) stage were the independent predictors associated with PMRT receipt (all P < 0.05). Patients who received PMRT showed better 3-year BCSS (OR = 0.720, 95% CI = 0.642–0.808, P < 0.001) than those that did not. The effect of PMRT on 3-year BCSS was analyzed after stratification by pathological staging of groups. The results showed that PMRT was associated with better 3-year BCSS in patients with stage T3–4N1 (P = 0.042), T1-4N2 (P < 0.001), and T1-4N3 (P < 0.001), while comparable 3-year BCSS was found between the PMRT and non-PMRT cohorts with T1–2N1 disease (P = 0.191). Conclusions Radiotherapy achieved better 3-year BCSS in TNBC patients with stage T3–4N1 and T1-4N2–3 disease. However, no survival benefit was found with the addition of PMRT in patients with T1–2N1 TNBC.

show abstract

Section: Discussionmentioning

confidence: 99%

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Cancer survivors are recommended to have regular follow up care in order to detect recurrence or secondary malignancies, and to assess and address any late effects of cancer treatment [2,9]. However, rates of follow-up care and associated cancer screenings are suboptimal [10,11]. While cancer survivors have higher rates of mammography and colorectal cancer screening than those without history of cancer, still many in these high-risk groups remain unscreened [12].…”

Section: Introductionmentioning

confidence: 99%

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

et al. 2019

View full text Add to dashboard Cite

Purpose: Our study aims to determine whether receipt of a written survivorship care plan (SCP) is associated with five self-reported health behaviors known to be correlated with positive longterm outcomes for cancer survivors: 1) attending a recent medical appointment, 2) exercise in the past month, 3) non-smoking status, 4) mammography in the past two years, and 5) up-to-date colorectal cancer screening. Methods: In this secondary data analysis, we used data from the 2014 Behavioral Risk Factor Surveillance System (BRFSS) cancer survivorship module for 1,855 off-treatment cancer survivors. Multivariable logistic regression accounting for complex survey design was used to examine the association between SCP receipt and each of the five preventive health behaviors. Results: Overall, 37% (669/1,855) of survivors reported receiving a written survivorship care plan. In the logistic regression models adjusted for sociodemographic and disease-related factors, SCP receipt was associated with having a recent medical appointment (OR (95% CI): 2.81 (1.27-6.22)), exercise in the past month (1.78 (1.20-2.63)), non-smoking status (2.27 (1.26-4.12)), and

show abstract

“…[ 8 9 10 ] Many patients are lost to follow-up after 5 years of primary treatment at oncology centers, even after the importance of follow-up visit is explained. [ 11 ]…”

Section: Introductionmentioning

confidence: 99%

Ten-year survival outcome of breast cancer patients in India

Patel¹,

Pavithran²,

Beena³

et al. 2021

J Carcinog

View full text Add to dashboard Cite

INTRODUCTION: Breast cancer is the most frequently diagnosed cancer among women in India; however, there are no studies addressing long-term survival (10 years and above). This study sought to evaluate long-term oncological outcome among women with breast cancer treated with a curative intent. MATERIALS AND METHODS: This is a retrospective cohort analysis of 1301 breast cancer patients of all stages who had received primary treatment with curative intent from 2004 to 2010 at a single cancer institution of India. RESULTS: A total of 1301 breast cancer patients were available for final analysis. The median age was 51 years (range, 21–86 years). 70.25% of the patients had early breast cancer (EBC), 21.9% had locally advanced breast cancer, and 7.85% of the patients with de novo metastatic disease also underwent surgery. 56.5% of the patients had hormone-sensitive tumors, human epidermal growth factor receptor 2 over expression was seen in 17%, and triple-negative tumors accounted for 26.2% of the patients. The 5- and 10-year overall survival (OS) of the entire cohort was 79% and 66%, and the 5- and 10-year breast cancer-specific survival (BCSS) was 79% and 70%, respectively. OS and BCSS were 51% and 58%, respectively, at 15-year follow-up after primary cancer treatment. On multivariate analysis, the factors associated with prolonged survival were age ≤50 years, EBC, and treatment during the later period (2008–2010). CONCLUSION: Difference between OS and BCSS was found to have an increasing trend during 10–15-year follow-up, the difference being 4% at 10 years and 7% at 15 years. Age ≤50 years, early-stage disease at presentation, and primary cancer treatment in later years (2008–2010) were favorable predictors for 10-year survival.

show abstract

“Lost to Follow-up” Among Adult Cancer Survivors

Cited by 25 publications

References 14 publications

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

The effect of postmastectomy radiotherapy in node-positive triple-negative breast cancer

Receipt of a survivorship care plan and self-reported health behaviors among cancer survivors

Ten-year survival outcome of breast cancer patients in India

Contact Info

Product

Resources

About